Department of Hematology, Christian Medical College, Vellore, India.
Haemophilia. 2013 Jul;19(4):611-8. doi: 10.1111/hae.12143. Epub 2013 Apr 8.
Congenital fibrinogen deficiency is an extremely rare (1:1 000 000) hereditary bleeding disorder caused by defects in genes coding for fibrinogen Aα-, Bβ- and γ-chains, respectively. We report here the molecular basis of fibrinogen deficiency in a large series of patients from India. Twenty-seven patients with clinical features suggestive of fibrinogen deficiency and with prolonged plasma clotting times and low fibrinogen levels were studied. Genomic DNA was screened for mutations in the fibrinogen alpha (FGA), beta (FGB), gamma (FGG) genes by PCR and conformation sensitive gel electrophoresis. Fourteen different disease-causing mutations including frameshifts (51.9%), splice site (22.2%), missense (18.5%) and nonsense mutation (7.4%) were identified in 27 patients. Thirteen of them were novel, including seven frameshifts (fibrinogen Aα: p.Asp296 fs59, p.Thr466 fs17 and p.Lys575 fs74; fibrinogen Bβ: p.Gly414 fs2 and fibrinogen γ: p.Ser81 fs5, p.Lys185 fs13 and p.Asp278_279 fs17), three splice site mutations (FGA gene c.364+1G>A; c.510+2 T>G; FGB gene c.851+1G>A), two missense substitutions (fibrinogen Bβ: p.Gly288Ser; p.Arg445Thr) and a nonsense mutation in fibrinogen Aα (p.Tyr127). Two common mutations (FGA: c.364+1G>A, n = 6, FGG: p.Lys185 fs*13, n = 7) affecting 13 patients were identified in this series, suggesting that these mutations could be screened first in Indian patients with fibrinogen deficiency. The molecular data presented here is the largest series of patients with fibrinogen deficiency reported so far, adding significantly to the mutation database of this condition. It also helps create an algorithm for its genetic diagnosis in India.
先天性纤维蛋白原缺乏症是一种极其罕见的遗传性出血性疾病(1:1 000 000),由纤维蛋白原 Aα-、Bβ-和 γ-链编码基因的缺陷引起。我们在此报告来自印度的一系列患者的纤维蛋白原缺乏症的分子基础。对 27 例具有纤维蛋白原缺乏临床特征、血浆凝固时间延长和纤维蛋白原水平降低的患者进行了研究。通过 PCR 和构象敏感凝胶电泳筛选纤维蛋白原 alpha(FGA)、beta(FGB)和 gamma(FGG)基因的基因突变。在 27 例患者中鉴定出 14 种不同的致病突变,包括移码突变(51.9%)、剪接位点突变(22.2%)、错义突变(18.5%)和无义突变(7.4%)。其中 13 种是新的,包括 7 种移码突变(纤维蛋白原 Aα:p.Asp296 fs59、p.Thr466 fs17 和 p.Lys575 fs74;纤维蛋白原 Bβ:p.Gly414 fs2 和纤维蛋白原 γ:p.Ser81 fs5、p.Lys185 fs13 和 p.Asp278_279 fs17)、3 种剪接位点突变(FGA 基因 c.364+1G>A;c.510+2 T>G;FGB 基因 c.851+1G>A)、2 种错义替换(纤维蛋白原 Bβ:p.Gly288Ser;p.Arg445Thr)和纤维蛋白原 Aα 的无义突变(p.Tyr127)。在该系列中,鉴定出 13 例患者的两种常见突变(FGA:c.364+1G>A,n=6,FGG:p.Lys185 fs*13,n=7),提示这些突变可首先在印度纤维蛋白原缺乏症患者中进行筛选。目前报道的纤维蛋白原缺乏症患者的分子数据是迄今为止最大的系列,大大增加了该疾病的突变数据库。它还有助于在印度建立其遗传诊断算法。